Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel | Zendy

Dror Mevorach | Zendy; Emilia Anis | Zendy; Noa Cedar | Zendy; Michal Bromberg | Zendy; Eric J. Haas | Zendy; Eyal Nadir | Zendy; Sharon Olsha-Castell | Zendy; Dana Arad | Zendy; Tal Hasin | Zendy; Nir Levi | Zendy; Rabea Asleh | Zendy; Offer Amir | Zendy; Karen Meir | Zendy; Dotan Cohen | Zendy; Rita Dichtiar | Zendy; Deborah Novick | Zendy; Yael Hershkovitz | Zendy; Ron Dagan | Zendy; Iris Leitersdorf | Zendy; Ronen BenAmi | Zendy; Ian Miskin | Zendy; Walid Saliba | Zendy; Khitam Muhsen | Zendy; Yehezkel Levi | Zendy; Manfred S. Green | Zendy; Lital Keinan-Boker | Zendy; Sharon AlroyPreis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

Author(s) -

Dror Mevorach,

Emilia Anis,

Noa Cedar,

Michal Bromberg,

Eric J. Haas,

Eyal Nadir,

Sharon Olsha-Castell,

Dana Arad,

Tal Hasin,

Nir Levi,

Rabea Asleh,

Offer Amir,

Karen Meir,

Dotan Cohen,

Rita Dichtiar,

Deborah Novick,

Yael Hershkovitz,

Ron Dagan,

Iris Leitersdorf,

Ronen BenAmi,

Ian Miskin,

Walid Saliba,

Khitam Muhsen,

Yehezkel Levi,

Manfred S. Green,

Lital Keinan-Boker,

Sharon AlroyPreis

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2109730

Subject(s) - covid-19 , virology , myocarditis , medicine , outbreak , infectious disease (medical specialty) , disease

Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) by May 31, 2021. After early reports of myocarditis during adverse events monitoring, the Israeli Ministry of Health initiated active surveillance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research